Horiba sets up new division and team

The Horiba Group, a manufacturer of systems and instruments for analysing and measuring gases, liquids and solids, has launched a new division called Horiba Medical, based in Northampton, UK, which specialises in automated in vitro diagnostics. Although the new name highlights Horiba Medical's 25-year clinical heritage, when known as ABX Diagnostics, the company caters for many other testing and monitoring environments with its compact benchtop chemistry and haematology analysers.

The new division is already established in specialist analysis and has installations in sports science, water testing, food and beverages, veterinary, nutraceuticals, pharmaceuticals and university clinical research laboratories.

In recognition of growing demand for its compact analysers in these sectors, Horiba Medical has now created a dedicated specialist analysis sales and support team in the UK to advise on applications.

Horiba Medical will benefit from all the technologies patented by its parent Horiba Group, which is listed on the Tokyo and Osaka Stock Exchanges and employs 5,000 people in 43 subsidiaries worldwide.

"Our specific aim is to ensure smooth and efficient analysis wherever it is required and the company has already successfully developed an array of automated analysers to meet all needs," said Cleve Wright, general manager, Horiba Medical UK. "We look forward to working even more closely with our sister companies within the Horiba Group."

Horiba Medical's products are designed, developed and distributed worldwide from its European headquarters in Montpellier, France.

Horiba Medical

T +44 1604 542650